Capillary leakage important in COVID-19 respiratory distress

NewsGuard 100/100 Score

The pandemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread to over 188 countries and territories, with over 5.4 million cases, leaving more than 344,000 dead. The chief cause of death is acute severe respiratory failure.

Now, a new study published on the preprint server medRxiv* reports the pivotal role played by protein leakage through lung capillaries and promotes the use of serum albumin as a biomarker of disease progression and severity.

Lung Disease in COVID-19

COVID-19 patients typically begin with mild cold-like symptoms, which progress from the early viral response phase through the lung phase to the hyperinflammation phase. The most severe phase of the disease is characterized by progressive respiratory failure with a lack of oxygenation, culminating in acute respiratory distress syndrome (ARDS).

Hyperimmune Response

This progression is thought by some scientists to be due to a hyperimmune response to the viral infection. This is characterized by elevated levels of proinflammatory cytokines and chemokines, which both signal the recruitment of more immune cells and the activation of inflammatory pathways. These cytokines include IL-1β, IL-6, and TNF-α.

The end result of this process is severe injury to the lung tissue as well as to multiple other organs. The most significant impact is on sites that have a high expression of ACE2, the host cell receptor for SARS-CoV-2, which produces the clinical feature of what is called viral sepsis.

SARS-CoV-2 viruses binding to ACE-2 receptors on a human cell, the initial stage of COVID-19 infection, conceptual 3D illustration. Credit: Kateryna Kon / Shutterstock
SARS-CoV-2 viruses binding to ACE-2 receptors on a human cell, the initial stage of COVID-19 infection, conceptual 3D illustration. Credit: Kateryna Kon / Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Direct Viral Insult

Electron microscopy shows the direct damage caused by the viral particles as well, confirmed by the presence of viruses in the bronchial cells and type II alveolar pneumocytes.

Endothelial Dysfunction

Another mechanism of injury is endothelial dysfunction. This is the result of the endothelial cell reaction to the invading virus, hypoxia, immune activation, and the effect of inflammatory mediators, including cell damage that causes histone release. In this way, there are multiple sources of endothelial damage, that increase the odds of inflammation, increased coagulation, and vasoconstriction.

The endothelial dysfunction occurring in many different organs causes both endothelial and immune cells to undergo programmed cell death or apoptosis. This may cause a breakdown of the epithelial-endothelial barrier, resulting in the presence of exudate in the alveolar cavity.

Chest Imaging Supports Exudative Edema

This mechanism is reflected in chest imaging results. The B lines, white lung and patchy pattern on lung ultrasound, as well as the ground glass opacities and slightly more dense hazy areas on chest CT, are the result of interstitial and alveolar lesions. Scientists have been looking into the reason for this alveolar exudate.

How Did the Study Examine Hypoalbuminemia in COVID-19?

The current study focuses on the presence of markedly reduced albumin levels in symptomatic COVID-19 patients, which could not be explained by the presence of protein loss in urine or the gut. Moreover, albumin infusion failed to correct the deficit.

The study was carried out on all patients aged 18 years and above, with lung disease due to COVID-19 confirmed by RT-PCR, from throat swab samples, and in whom serum albumin was measured within 72 hours of admission, in a single hospital in Milan, Italy. The study period was from February 21 to April 15, 2020.

Patients who failed to sustain respiratory function with helmet-mediated continuous positive airway pressure (CPAP) were admitted to the intensive care unit (ICU)

How Was Hypoalbuminemia Related To COVID-19 Lung Disease?

There was no significant difference in demographic and medical characteristics between the different groups in the trial. Patients in the ICU were more likely to be male, while intermediate medical ward (IMW) inpatients were more often smokers, or had a history of heart disease, stroke, or diabetes.

The symptom onset to admission duration was shorter in ICU patients at about six days, on average, vs. eight days for medical ward admissions. However, there was no difference in the time from admission to the initiation of CPAP. Nonetheless, the initial positive end-expiratory pressure was higher at this point in ICU vs. IMW patients.

ICU patients stayed in hospital for an average of 20 days compared to 8 days for IMW patients, and they also had more than double the mortality compared to IMW patients ((52.4% vs. 21.7%). This trend also held good when patients were compared based on the median albumin level, 24 g/L, at survival rates of 53.2% vs. 21%.

Serum biomarkers of inflammation and organ dysfunction were higher in ICU patients, but lymphocytes counts were reduced markedly in this group.

Albumin Levels and Outcome

In all patients, mean serum albumin levels were low, but more markedly in ICU than in IMW patients, at 20 vs. 28 g/L. The greatest negative impact on respiratory function was in ICU patients.

Within 48 hours of admission, the spot protein measurements for 77 ICU patients were undetectable in 95%. The median quantitative proteinuria measurement for 12 ICU patients was 76 mg. Among all patients, only one had a history of any condition that could account for such massive protein loss.

The investigators then classified the patients into three subgroups based on either the P/F ratio or the Brixia score on chest X-ray. They found that the worse the respiratory function, the lower was the albumin level, on average.

The three P/F categories were > 250, 250-150, and <150, with corresponding median albumin levels of 31, 24, and 20 g/L, respectively.

The falling albumin levels were linked to rising levels of IL-8, which is inflammatory in function, and inversely proportional to the anti-inflammatory IL-10.

When the chest X-ray showed more extensive and marked lung changes, the Brixia scores <5, 6-11, and ≥ 12 were associated with albumin levels of 31, 27, and 21 g/L, respectively. The corresponding microscopic tissue changes in the lung tissue included loss of alveolar membranes and the deposition of hyaline membranes in the alveoli. In addition, the interstitial tissue showed patchy swelling by a mild proliferation of fibrous tissue, edema, and lymphocyte invasion to a moderate degree.

Electron microscopy revealed that junctional complexes that are mostly responsible for the epithelial integrity were strikingly disrupted in 80% of examined samples (8/10 patients), with surfactant loss in type 2 pneumocytes. Viral particles were also present in the cytoplasm of these cells and the endothelium.

The Implications for Future Practice

The conclusion is inescapable that the hypoalbuminemia linked to COVID-19 lung disease is commensurate with the severity of respiratory distress.

The scientists theorize that the virus causes pulmonary capillary leakage mediated by the intense inflammatory reaction, which is a major cause of the disease manifestations as well as the laboratory and imaging results.

A reduction of serum albumin is frequently observed in inflammation and acute illness. The reasons include increases in the permeability of blood vessels, with albumin entering extravascular spaces more freely while it is more readily broken down.

Even though the synthesis of albumin is increased in such states, including trauma, infection or shock, the intracellular breakdown of albumin results in a lower total mass, and this indicates a poorer outcome as well as a negative response to a second insult, such as surgery. On the other hand, albumin administration systemically is not consistently linked to a better outcome in such patients, except in the case of septic shock.

In acute influenza A and other viral pneumonias, the virus directly injures the epithelium-endothelial barrier causing exudative edema, with rich protein content. Endothelial cells form almost a third of all cell types in the lungs, and thus. However, their contribution to limiting protein flux is relatively limited, the summated effect is very significant.

Autopsy of patients in the current study showed that both sides of the barrier were extensively damaged, allowing increased passage of both fluid and protein from the blood to the lung alveoli. Endothelial damage may also trigger coagulation pathways, which act together with a capillary fluid loss to cause clotting within the microcirculation.

As a result of such findings, drug trials are underway to test the efficacy and safety of drugs that prevent the leakage of blood and fluids from the capillaries into the lung alveolar space or avert disruption of the epithelial barrier.

The researchers advise, in conclusion: “Further research is needed to get deeper insights into the mechanisms leading to this condition, and to identify new potential therapeutic targets to mitigate or even avoid endothelial dysfunction.”

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Mar 21 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2023, March 21). Capillary leakage important in COVID-19 respiratory distress. News-Medical. Retrieved on May 25, 2024 from https://www.news-medical.net/news/20200524/Capillary-leakage-important-in-COVID-19-respiratory-distress.aspx.

  • MLA

    Thomas, Liji. "Capillary leakage important in COVID-19 respiratory distress". News-Medical. 25 May 2024. <https://www.news-medical.net/news/20200524/Capillary-leakage-important-in-COVID-19-respiratory-distress.aspx>.

  • Chicago

    Thomas, Liji. "Capillary leakage important in COVID-19 respiratory distress". News-Medical. https://www.news-medical.net/news/20200524/Capillary-leakage-important-in-COVID-19-respiratory-distress.aspx. (accessed May 25, 2024).

  • Harvard

    Thomas, Liji. 2023. Capillary leakage important in COVID-19 respiratory distress. News-Medical, viewed 25 May 2024, https://www.news-medical.net/news/20200524/Capillary-leakage-important-in-COVID-19-respiratory-distress.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections